Home  »  Industry   »  Who are the Institutional Holders in Hims & H...

Who are the Institutional Holders in Hims & Hers Health Inc. (HIMS)?

Hims & Hers Health Inc. (NYSE: HIMS) is -4.27% lower on its value in year-to-date trading and has touched a low of $2.72 and a high of $7.28 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HIMS stock was last observed hovering at around $5.89 in the last trading session, with the day’s gains setting it 0.38% off its average median price target of $7.00 for the next 12 months. It is also 47.75% off the consensus price target high of $12.00 offered by 9 analysts, but current levels are -25.4% lower than the price target low of $5.00 for the same period.

Currently trading at $6.27, the stock is 20.47% and 20.37% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.9 million and changing 6.45% at the moment leaves the stock 23.46% off its SMA200. HIMS registered -6.42% loss for a year compared to 6-month gain of 74.65%.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


The stock witnessed a 44.80% loss in the last 1 month and extending the period to 3 months gives it a -1.72%, and is 8.48% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.57% over the week and 7.03% over the month.

Hims & Hers Health Inc. (HIMS) has around 398 employees, a market worth around $1.31B and $373.70M in sales. Profit margin for the company is -22.20%. Distance from 52-week low is 130.51% and -13.87% from its 52-week high. The company has generated returns on investments over the last 12 months (-33.50%).

Hims & Hers Health Inc. (HIMS) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Hims & Hers Health Inc. (HIMS) is a “Overweight”. 9 analysts offering their recommendations for the stock have an average rating of 2.20, where 5 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Hims & Hers Health Inc. is expected to release its quarterly report on 03/14/2023.The EPS is expected to shrink by -375.60% this year

Hims & Hers Health Inc. (HIMS) Top Institutional Holders

The shares outstanding are 203.95M, and float is at 156.42M with Short Float at 8.43%.

Hims & Hers Health Inc. (HIMS) Insider Activity

A total of 37 insider transactions have happened at Hims & Hers Health Inc. (HIMS) in the last six months, with sales accounting for 16 and purchases happening 21 times. The most recent transaction is an insider sale by Boughton Soleil, the company’s Chief Legal Officer. SEC filings show that Boughton Soleil sold 2,000 shares of the company’s common stock on Nov 14 at a price of $5.80 per share for a total of $11600.0. Following the sale, the insider now owns 0.31 million shares.

Hims & Hers Health Inc. disclosed in a document filed with the SEC on Nov 09 that Boughton Soleil (Chief Legal Officer) sold a total of 20,000 shares of the company’s common stock. The trade occurred on Nov 09 and was made at $6.00 per share for $0.12 million. Following the transaction, the insider now directly holds 0.31 million shares of the HIMS stock.

Still, SEC filings show that on Oct 18, Boughton Soleil (Chief Legal Officer) disposed off 5,545 shares at an average price of $4.44 for $24620.0. The insider now directly holds 330,271 shares of Hims & Hers Health Inc. (HIMS).

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.